Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Jun 5;10(6):911-3.
doi: 10.2215/CJN.04300415. Epub 2015 May 15.

BP Components in Advanced CKD and the Competing Risks of Death, ESRD, and Cardiovascular Events

Arjun D Sinha  1 , Rajiv Agarwal  2
Affiliations
Editorial

BP Components in Advanced CKD and the Competing Risks of Death, ESRD, and Cardiovascular Events

Arjun D Sinha et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: BP; advanced kidney disease; outcomes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relationship between increasing systolic BP and competing outcomes in CKD. A higher systolic BP is a risk factor for ESRD, but a lower systolic BP is a marker for all-cause mortality in a competing risk model (data from ref. 8).
See this image and copyright information in PMC

Comment on

References

    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047, 2007 - PubMed
    1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305, 2004 - PubMed
    1. Palit S, Chonchol M, Cheung AK, Kaufman J, Smits G, Kendrick J: Association of BP with death, cardiovascular events, and progression to chronic dialysis in patients with advanced kidney disease. Clin J Am Soc Nephrol 10: 934–940, 2015 - PMC - PubMed
    1. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM; Veterans Affairs Site Investigators: Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: A randomized controlled trial. JAMA 298: 1163–1170, 2007 - PubMed
    1. Anderson AH, Yang W, Townsend RR, Pan Q, Chertow GM, Kusek JW, Charleston J, He J, Kallem R, Lash JP, Miller ER, 3rd, Rahman M, Steigerwalt S, Weir M, Wright JT, Jr., Feldman HI; Chronic Renal Insufficiency Cohort Study Investigators: Time-updated systolic blood pressure and the progression of chronic kidney disease: A cohort study. Ann Intern Med 162: 258–265, 2015 - PMC - PubMed